RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/16225
https://w3id.org/ripe/ripe-kg/retraction-notice/16225
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA6DBDE4E81DF5F0FA |
prov:used |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
prism:doi |
10.1016/j.bone.2017.10.008 |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
prism:publicationDate |
2017-11-14 |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
prism:publicationName |
Bone |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
dcterms:publisher |
ripekg:publisher/RIPEP89ABFFE2696381B7Elsevier |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
dcterms:title |
Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1016%2Fj.bone.2006.04.025 |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
rdf:type |
owl:Thing |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
owl:sameAs |
https://semopenalex.org/work/W4235099136 |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA6DBDE4E81DF5F0FA |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA6DBDE4E81DF5F0FA |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
ripe:concerns |
ripekg:work/10.1016%2Fj.bone.2006.04.025 |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
ripe:rationale |
Falsification/Fabrication of Data;False/Forged Authorship;Investigation by Company/Institution;Investigation by Journal/Publisher;Misconduct - Official Investigation(s) and/or Finding(s);Misconduct by Author |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
ripe:retractionWatchRecordId |
16225 |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA6DBDE4E81DF5F0FA-human-1-1 |
ripekg:retraction-notice/16225Etidronate for fracture prevention in amyotrophic lateral sclerosis: A randomized controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA6DBDE4E81DF5F0FA-inspectai-1-1 |